tiprankstipranks
Halozyme Therapeutics (HALO)
:HALO
US Market

Halozyme (HALO) Technical Analysis

Compare
964 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is 1.32, suggesting Halozyme Therapeutics is a Buy.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 56.73, while Halozyme Therapeutics’s (HALO) share price is $57.44, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 54.59, while Halozyme Therapeutics’s (HALO) share price is $57.44, making it a Buy.

Halozyme (HALO) Pivot Points

Feb 21, 2025, 04:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
52.24
54.50
56.14
58.40
60.04
62.30
63.94
Fibonacci
54.50
55.99
56.91
58.40
59.89
60.81
62.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Feb 21, 2025, 04:34 PM
Period
Simple
Exponential
MA5
58.00Sell
57.76Sell
MA10
57.78Sell
57.60Sell
MA20
57.03Buy
56.73Buy
MA50
52.85Buy
54.59Buy
MA100
52.81Buy
53.45Buy
MA200
53.00Buy
51.25Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 57.60, while Halozyme Therapeutics’s (HALO) share price is $57.44, making it a Sell.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 53.45, while Halozyme Therapeutics’s (HALO) share price is $57.44, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $57.44 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 52.85, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $57.44 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 52.81, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $57.44 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 53.00, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Feb 21, 2025, 04:34 PM
Name
Value
Implied Action
RSI (14)
61.10
Neutral
STOCH (9,6)
36.06
Neutral
STOCHRSI (14)
52.95
Neutral
MACD (12,26)
1.32
Buy
ADX (14)
38.89
Neutral
Williams %R
-56.57
Buy
CCI (14)
4.15
Neutral
ATR (14)
1.52
-
Ultimate Oscillator
51.26
Neutral
ROC
1.81
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 61.10, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 38.89, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is 4.15, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 1.81, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Buy.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 61.10, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is 1.32, which suggests HALO is a Buy.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 58.00, which suggests HALO is a Sell.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 57.03, which suggests HALO is a Buy.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 52.85, which suggests HALO is a Buy.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 53.00, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -56.57, which suggests HALO is a Buy.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is 4.15, which suggests HALO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis